Cargando…
Use and perceived benefits and barriers of QSAR models for REACH: findings from a questionnaire to stakeholders
The ORCHESTRA online questionnaire on “benefits and barriers to the use of QSAR methods” addressed the academic, consultant, regulatory and industry communities potentially interested by QSAR methods in the context of REACH. Replies from more than 60 stakeholders produced some insights on the actual...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3771413/ https://www.ncbi.nlm.nih.gov/pubmed/23244245 http://dx.doi.org/10.1186/1752-153X-6-159 |
_version_ | 1782284192974897152 |
---|---|
author | Mays, Claire Benfenati, Emilio Pardoe, Simon |
author_facet | Mays, Claire Benfenati, Emilio Pardoe, Simon |
author_sort | Mays, Claire |
collection | PubMed |
description | The ORCHESTRA online questionnaire on “benefits and barriers to the use of QSAR methods” addressed the academic, consultant, regulatory and industry communities potentially interested by QSAR methods in the context of REACH. Replies from more than 60 stakeholders produced some insights on the actual application of QSAR methods, and how to improve their use. Respondents state in majority that they have used QSAR methods. All have some future plans to test or use QSAR methods in accordance with their stakeholder role. The stakeholder respondents cited a total of 28 models, methods or software that they have actually applied. The three most frequently cited suites, used moreover by all the stakeholder categories, are the OECD Toolbox, EPISuite and CAESAR; all are free tools. Results suggest that stereotyped assumptions about the barriers to application of QSAR may be incorrect. Economic costs (including potential delays) are not found to be a major barrier. And only one respondent “prefers” traditional, well-known and accepted toxicological assessment methods. Information and guidance may be the keys to reinforcing use of QSAR models. Regulators appear most interested in obtaining clear explanation of the basis of the models, to provide a solid basis for decisions. Scientists appear most interested in the exploration of the scientific capabilities of the QSAR approach. Industry shows interest in obtaining reassurance that appropriate uses of QSAR will be accepted by regulators. |
format | Online Article Text |
id | pubmed-3771413 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-37714132013-09-13 Use and perceived benefits and barriers of QSAR models for REACH: findings from a questionnaire to stakeholders Mays, Claire Benfenati, Emilio Pardoe, Simon Chem Cent J Short Report The ORCHESTRA online questionnaire on “benefits and barriers to the use of QSAR methods” addressed the academic, consultant, regulatory and industry communities potentially interested by QSAR methods in the context of REACH. Replies from more than 60 stakeholders produced some insights on the actual application of QSAR methods, and how to improve their use. Respondents state in majority that they have used QSAR methods. All have some future plans to test or use QSAR methods in accordance with their stakeholder role. The stakeholder respondents cited a total of 28 models, methods or software that they have actually applied. The three most frequently cited suites, used moreover by all the stakeholder categories, are the OECD Toolbox, EPISuite and CAESAR; all are free tools. Results suggest that stereotyped assumptions about the barriers to application of QSAR may be incorrect. Economic costs (including potential delays) are not found to be a major barrier. And only one respondent “prefers” traditional, well-known and accepted toxicological assessment methods. Information and guidance may be the keys to reinforcing use of QSAR models. Regulators appear most interested in obtaining clear explanation of the basis of the models, to provide a solid basis for decisions. Scientists appear most interested in the exploration of the scientific capabilities of the QSAR approach. Industry shows interest in obtaining reassurance that appropriate uses of QSAR will be accepted by regulators. BioMed Central 2012-12-18 /pmc/articles/PMC3771413/ /pubmed/23244245 http://dx.doi.org/10.1186/1752-153X-6-159 Text en Copyright © 2012 Mays et al.; licensee Chemistry Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Short Report Mays, Claire Benfenati, Emilio Pardoe, Simon Use and perceived benefits and barriers of QSAR models for REACH: findings from a questionnaire to stakeholders |
title | Use and perceived benefits and barriers of QSAR models for REACH: findings from a questionnaire to stakeholders |
title_full | Use and perceived benefits and barriers of QSAR models for REACH: findings from a questionnaire to stakeholders |
title_fullStr | Use and perceived benefits and barriers of QSAR models for REACH: findings from a questionnaire to stakeholders |
title_full_unstemmed | Use and perceived benefits and barriers of QSAR models for REACH: findings from a questionnaire to stakeholders |
title_short | Use and perceived benefits and barriers of QSAR models for REACH: findings from a questionnaire to stakeholders |
title_sort | use and perceived benefits and barriers of qsar models for reach: findings from a questionnaire to stakeholders |
topic | Short Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3771413/ https://www.ncbi.nlm.nih.gov/pubmed/23244245 http://dx.doi.org/10.1186/1752-153X-6-159 |
work_keys_str_mv | AT maysclaire useandperceivedbenefitsandbarriersofqsarmodelsforreachfindingsfromaquestionnairetostakeholders AT benfenatiemilio useandperceivedbenefitsandbarriersofqsarmodelsforreachfindingsfromaquestionnairetostakeholders AT pardoesimon useandperceivedbenefitsandbarriersofqsarmodelsforreachfindingsfromaquestionnairetostakeholders |